8 followers
Adverum Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. Adverum is evaluating its novel gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet ag... Read more
Laurent Fischer
This company has no offices yet
Fortis Life Sciences
1 follower
Solugen
2 followers
CHDI Foundation
5 followers
Cerapedics
1 follower
Affinia Therapeutics
1 follower
Thermo Fisher Scientific
173 followers
Gilead Sciences
133 followers
Biogen
119 followers
Formation Bio
2 followers
Alexion Pharmaceuticals
34 followers
Kura Oncology
19 followers
Explore companies